Results 151 to 160 of about 4,832,495 (330)
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Stability of Composite Plates with a Dense System of Ribs in Two Directions. [PDF]
Marczak J, Rabenda M, Michalak B.
europepmc +1 more source
Using Bayesian Model Averaging to Calibrate Forecast Ensembles
A. Raftery +3 more
semanticscholar +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Optimizing Measurement Parameters for Ocular Surface Temperature Assessment Using ResearchIR Software. [PDF]
Monfared M, Murphy PJ.
europepmc +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Implementation of Replica-Averaged Restraints from Nuclear Magnetic Resonance Measurement with UNRES Coarse Grained Model of Polypeptide Chains. [PDF]
Shirkov L, Czaplewski C, Liwo A.
europepmc +1 more source
Gauss–Bonnet–Chern approach to the averaged Universe [PDF]
Léo Brunswic, Thomas Buchert
openalex +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Personalizing the Pressure Reactivity Index for Quantifying Cerebral Autoregulation in Neurocritical Care. [PDF]
Briggs JK +5 more
europepmc +1 more source

